Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 3.975
-0.100 (-2.45%)
Aug 20, 2026, 5:25 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €962.84 million as of August 20, 2026. Its market cap has increased by 89.63% in one year.
Market Cap
962.84M
Enterprise Value
1.09B
Revenue
6.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.98
ChartMarket Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 962.84M, an increase of 615.63%. That is a compound annual growth rate of 22.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 962.84M | 27.76% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 8.87B |
| Nanobiotix | 1.93B |
| MedinCell | 893.48M |
| DBV Technologies | 752.81M |
| Genfit | 720.35M |
| Valneva SE | 558.89M |
| Valerio Therapeutics Société anonyme | 382.08M |
| Transgene | 230.06M |